fbpx Treatment and Intervention | Page 2 | NDARC - National Drug and Alcohol Research Centre

Treatment and Intervention

An open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence

image - CoLAB

Retaining patients in buprenorphine treatment is essential in maximising treatment outcomes and minimising mortality risk. Delivery of treatment via novel depot buprenorphine products has the potential to enhance patient adherence and retention in treatment.

Project Status: 
Current

Exploration of partnerships between rural Aboriginal communities and researchers to prevent and treat drug and alcohol-related harms: Three examples in remote NSW

image - Aboriginal Women Square Copy

This project seeks to develop knowledge about effective models of partnership between rural Aboriginal communities and researchers across a range of community-led programs delivered from 2012-2016, which aimed to reduce drug and alcohol-related harm.

Project Status: 
Current